AFS-14-125-E 

March 26, 2014 

 Exemption No. 10721A 

 Regulatory Docket No. FAA-2013-0201 

Ms. Stacy Bechdolt, Esq. 

Director, Safety and Technical Affairs 

Regional Airline Association 

2025 M Street, NW., Suite 800 

Washington, DC 20036 

Mr. Robert Ireland 

Managing Director, Engineering and Maintenance 

Airlines for America 

1301 Pennsylvania Avenue, NW., Suite 1100 

Washington, DC 20004 

Mr. George Paul 

Director of Technical Services 

National Air Carrier Association 

1000 Wilson Boulevard, Suite 1700 

Arlington, VA 22209 

Dear Ms. Bechdolt, Messrs. Ireland and Paul: 

This letter is to inform you that we have granted your petition to extend Exemption 

No. 10721. It explains the basis for our decision, describes its effect, and lists the revised 

conditions and limitations. 

The Basis for Our Decision 

By letters dated January 16, 2014 and January 24, 2014, Regional Airline Association (RAA), 

Airlines for America (A4A), and National Air Carrier Association (NACA) petitioned the 

Federal Aviation Administration (FAA) on behalf of their passenger airlines and similarly- 
 2

situated air carriers for an extension and amendment to Exemption No. 10721. The petitioners 

have requested certain additional terms that, if granted, would remedy complications arising 

from the limitations of the originally granted exemption. 

Specifically, the petitioners requested the following: 

 The extension of Exemption No. 10721 pertaining to Dextrose, that expires on 

March 30, 2014. 

 The extension should allow kits to remain in the field that are short of the substances 

until normally returned for refurbishment (“grandfathering”), regardless of recovery of 

market supplies. The intent is to continue extensions for some period after supplies 

are restored to avoid a sudden need to refurbish kits off-schedule, unreasonably 

straining supply capabilities. 

 Carriers may use their own effective means to communicate that kits already in the 

field are covered by the proposed extension despite the expiration date of March 30, 

2014 that may be apparent. 

 The extension should stipulate that it must be readily apparent that kits not containing 

Dextrose are in compliance with Exemption No. 10721 “as revised or extended”, 

without displaying the expiration date. 

 Deletion of the requirement to carry a copy of the Exemption on board the affected 

aircraft. 

The petitioners’ current exemption from § 121.803(c)(3) and part 121, Appendix A of 

Title 14, Code of Federal Regulations (14 CFR) allows carriers relief from the requirement to 

include Dextrose in an Emergency Medical Kit (EMK). A condition of that exemption 

includes a requirement to carry a copy of the exemption aboard the affected aircraft. 

The petitioners indicate that there has been no change in the conditions and reasons relative to 

public interest and safety that were the basis for granting the original exemption. 

The FAA has determined that good cause exists for not publishing a summary of the petition 

in the Federal Register because the requested extension and amendment to the exemption 

would not set a precedent, and any delay in acting on this petition would be detrimental to 

RAA, A4A, and NACA. 

Our Decision 

The FAA has determined that the justification for the issuance of Exemption No. 10721 

remains valid with respect to this exemption and is in the public interest. Therefore, under the 

authority provided by 49 U.S.C. §§ 106(f), 40113, and 44701, which the FAA Administrator 
 3

has delegated to me, passenger member airlines of Regional Airline Association, Airlines for 

America, and National Air Carrier Association, and all similarly- situated air carriers, are 

granted an extension of its exemption from 14 CFR § 121.803(c)(3) and part 121, Appendix 

A to the extent necessary to relieve them from the requirement to carry one single dose 

ampule of Dextrose 50cc injectable required in on board EMKs when, due to the nationwide 

shortage discussed herein, they are unable to procure these items for the kits. 

With regards to the request to amend the conditions and limitations, the FAA denies the 

petitioners’ request to waive the requirements to maintain a copy of the most current 

exemption with the expiration date on board the affected aircraft, as it is not in the public 

interest. This exemption is subject to the following conditions and limitations. 

Conditions and Limitations 

1. This exemption applies to the part 119 certificate holders authorized to conduct 

part 121 passenger carrying operations. 

2. A copy of this exemption must be carried on board each aircraft operating with 

emergency medical kits that do not include Dextrose as required by part 121, 

Appendix A. 

3. As part of the requirement under §119.43(c) to keep each of its employees and other 

persons used in its operation informed of the provisions of their operations 

specifications that apply to that employee’s or person’s duties and responsibilities, the 

certificate holders must inform crewmembers that any emergency medical kits on 

board the aircraft may not contain Dextrose. 

4. This exemption may be used for flights conducted outside of the United States. 

This exemption terminates on March 31, 2016, unless sooner superseded or rescinded. 

Sincerely, 

/s/ 

John S. Duncan 

Director, Flight Standards Service